Inhibitory effects of glycopolymers having globotriose and/or lactose on cytotoxicity of Shiga toxin 1
- 1 January 2007
- journal article
- research article
- Published by Elsevier in Carbohydrate Polymers
- Vol. 67 (2), 260-264
- https://doi.org/10.1016/j.carbpol.2006.05.020
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Oral Therapeutic Agents with Highly Clustered Globotriose for Treatment of Shiga ToxigenicEscherichia coliInfectionsThe Journal of Infectious Diseases, 2004
- A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7Proceedings of the National Academy of Sciences, 2002
- The use of Shiga-like toxin 1 in cancer therapyCritical Reviews in Oncology/Hematology, 2001
- Synthesis of an artificial glycoconjugate polymer carrying Pk-antigenic trisaccharide and its potent neutralization activity against Shiga-like toxinBioorganic & Medicinal Chemistry, 1999
- Investigation of Shiga-like Toxin Binding to Chemically Synthesized Oligosaccharide SequencesThe Journal of Infectious Diseases, 1991
- Verotoxin Receptor Glycolipid in Human Renal TissueNephron, 1989
- Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.Journal of Biological Chemistry, 1987
- Purification and some properties of Shiga-like toxin from Escherichia coli 0157:H7 that is immunologically identical to Shiga toxinMicrobial Pathogenesis, 1987
- Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1.Journal of Biological Chemistry, 1987
- Pathogenesis of shigella diarrhea. VII. Evidence for a cell membrane toxin receptor involving β1 {arrow} 4-linked N-acetyl-D-glucosamine oligomersThe Journal of Experimental Medicine, 1977